Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow CAH
Cardinal Health, Inc. (CAH) EBITDA
Cardinal Health, Inc.'s EBITDA for fiscal 2026 was $3.6B, up 16.4% from $3.1B in fiscal 2025. Over the past ten years it has ranged from −$3.2B (fiscal 2020) to $3.6B (fiscal 2026) — the current reading is the highest in ten years. EBITDA has risen for 4 consecutive fiscal years. Cardinal Health, Inc. ranks 3rd of 10 Medical Distribution companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2026 | $3.6B | 16.44% |
| FY2025 | $3.1B | 56.94% |
| FY2024 | $2.0B | 35.25% |
| FY2023 | $1.4B | 1,598.82% |
| FY2022 | $85.0M | (93.23%) |
| FY2021 | $1.3B | — |
| FY2020 | −$3.2B | — |
| FY2019 | $3.1B | 164.25% |
| FY2018 | $1.2B | (59.18%) |
| FY2017 | $2.8B | (8.48%) |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $970.0M | 28.14% |
| Mar 2026 | $757.0M | (19.55%) |
| Dec 2025 | $941.0M | 4.44% |
| Sep 2025 | $901.0M | 41.44% |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| MCK McKesson Corporation compare | $7.3B |
| COR Cencora, Inc. compare | $4.1B |
| CAH Cardinal Health, Inc. | $3.6B |
| HSIC Henry Schein, Inc. compare | $1.0B |
| ACH Accendra Health, Inc. compare | $285.4M |
| COSM Cosmos Health Inc. compare | −$16.9M |
| FOCL FocalTherics compare | −$25.3M |
| AHG Akso Health Group Sponsored ADR compare | −$30.3M |
| HKPD Cellyan Biotechnology Co., Ltd compare | — |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on CAH
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement